BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8178752)

  • 1. [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection].
    Sakurai M; Sugimura Y; Arima K; Kawamura J; Saitou K; Tajima K; Nakano S; Satani H; Nagano M; Hoshina A
    Hinyokika Kiyo; 1994 Mar; 40(3):279-84. PubMed ID: 8178752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical studies on tosufloxacin (TFLX) in urology].
    Fukushima S; Moriyama M; Miyamoto H; Hosaka M; Kubota Y; Kinoshita Y; Noguchi K; Shuin T; Noguchi S; Yoshimura S
    Hinyokika Kiyo; 1992 Apr; 38(4):501-6. PubMed ID: 1529827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of tosufloxacin on the patients with urinary tract infections].
    Yoshida K; Kobayashi N; Saitoh H; Negishi T; Yamada T; Watanabe T; Kawakami S; Tari K; Satake I; Ozawa K
    Hinyokika Kiyo; 1992 Jan; 38(1):129-34. PubMed ID: 1546562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
    Washida H; Sakagami H; Iwase Y; Sasaki S
    Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive chemotherapy after transurethral prostatectomy: a randomized study].
    Yoshida O; Arai Y; Takeuchi H; Fukuyama T; Hida S; Ikeda T; Okabe T; Kuo SY; Kounami T; Nakagawa T
    Hinyokika Kiyo; 1993 May; 39(5):491-6. PubMed ID: 7686715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies of tosufloxacin on chronic bacterial prostatitis].
    Ikeuchi T; Kawamura N; Suzuki K; Onodera S; Osada T; Hirano A; Satomi Y; Yoshimura S; Yamamoto Y
    Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmonella excretion after cessation of tosufloxacin therapy in acute nontyphoid salmonella enterocolitis.
    Ohnishi K; Kimura K
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1892-3. PubMed ID: 11353646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988].
    Suzuki K; Nagata Y
    Hinyokika Kiyo; 1989 Apr; 35(4):717-26. PubMed ID: 2735274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection].
    Sasaki J; Kaneko A; Karakida K; Shiiki K; Sakamoto H; Naitoh H; Yamane N; Tomita F; Katoh H; Yoshida H
    Jpn J Antibiot; 1995 Sep; 48(9):1093-118. PubMed ID: 7474331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
    Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
    Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of complicated urinary tract infections by ofloxacin].
    Yoshida K; Takahashi T; Nakame Y; Saitoh H; Negishi T; Horiuchi S; Kaneoya F; Tari K; Satake I; Kojima S
    Hinyokika Kiyo; 1988 Feb; 34(2):394-401. PubMed ID: 3163876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of clinical efficacy and safety of long-term cinoxacin therapy of chronic urogenital organ infection].
    Hayashi Y; Terao E; Yamasaki I
    Hinyokika Kiyo; 1987 May; 33(5):799-805. PubMed ID: 3661347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae].
    Sakata H
    Jpn J Antibiot; 2012 Jun; 65(3):173-9. PubMed ID: 23173293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic prophylaxis for transurethral resection of the prostate--comparison of oral administration therapy with intravenous administration therapy].
    Tsuji Y; Okamura K; Miyake K; Ito H; Kinukawa T; Otani T; Narushima M; Kanai S; Takagi Y; Murase T
    Hinyokika Kiyo; 1993 Dec; 39(12):1145-52. PubMed ID: 7506866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
    Guibert J; Herman H; Capron MH
    Contracept Fertil Sex; 1997 Jan; 25(1):79-84. PubMed ID: 9064058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tavanik effectiveness and safety in the treatment of urinary tract infection complications].
    Loran OB; Pushkar' DIu; Rasner PI
    Klin Med (Mosk); 2001; 79(12):35-8. PubMed ID: 11840809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient compliance and efficacy of low-dose, long-term prophylaxis in patients with recurrent urinary tract infection.
    Westenfelder M; Vahlensieck W; Reinhartz U
    Chemioterapia; 1987 Jun; 6(2 Suppl):530-2. PubMed ID: 3509492
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women.
    Melekos MD; Asbach HW; Gerharz E; Zarakovitis IE; Weingaertner K; Naber KG
    J Urol; 1997 Mar; 157(3):935-9. PubMed ID: 9072603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoxacin for the treatment of urinary tract infection.
    Bailey RR; Peddie BA
    N Z Med J; 1985 Apr; 98(777):286-8. PubMed ID: 3857511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.